![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
EU WC
Listed Suppliers
USA (Orange Book)
0
Europe
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
0
0
https://www.clinicaltrialsarena.com/news/neurana-enrolment-muscle-spasm/
https://www.prnewswire.com/news-releases/neurana-pharmaceuticals-to-present-at-napa-pain-conference-and-pain-week-301364884.html
https://www.prnewswire.com/news-releases/neurana-pharmaceuticals-announces-50-enrollment-in-phase-3-resume-1-study-301305651.html
https://www.prnewswire.com/news-releases/neurana-pharmaceuticals-announces-top-line-results-from-tolperisone-phase-1-cns-effects-study-301188774.html
http://www.prnewswire.com/news-releases/katama-pharmaceuticals-receives-a-notice-of-allowance-of-a-composition-of-matter-patent-for-tolperisone-300233171.html